Diabetes Digital Therapeutics for Healthcare Payers — ESP Vendor Matrix
Glooko was named a leader in diabetes digital therapeutics for healthcare payers by CB Insights. The ranking reinforces the company’s commitment...
How Technologies Are Personalizing At-Home Diabetes Care
Seemingly overnight, healthcare discovered and fully embraced digital health solutions. Just months after the 2020 nationwide lockdown, telehealth visits,...
Remote Patient Monitoring: A Platform for Innovations in Interdisciplinary Care Management
The aftershocks of COVID-19 continue to reverberate throughout the U.S. healthcare system. For example, the pandemic has forever dispelled the quaint notion...
Commercializing Digital Therapeutic Solutions: Key Lessons Learned to Watch
The pandemic has set ablaze the white-hot market for Digital Therapeutics (DTx), which “deliver medical interventions directly to patients using evidence-based,...
Misconceptions and Truths about Remote Patient Monitoring
In recent years, there has been a great deal of talk in healthcare circles about remote patient monitoring (RPM), a trend that has only accelerated over...
Glooko’s Remote Patient Monitoring for People with Diabetes
In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Russ Johannesson,...
ADA 2021 Study Outlines Benefits of RPM on Glycemic Control in Patients with Type 2 Diabetes
A study assessing use of remote patient monitoring in patients with type 2 diabetes outlines the impact continued participation in digital monitoring programs...
ADA21: Glooko Study Finds Diabetes Remote Monitoring Helps Keep Glucose Levels in Check
According to study findings presented by Glooko at the American Diabetes Association (ADA) scientific sessions on Friday, remote patient monitoring (RPM)...
Lilly inks smart insulin pen deals with Roche, Dexcom and more
The company aims to secure a CE mark for the Tempo Smart Button by the end of this year, enabling it and the Tempo Pen to be sold as a single package in...
Glooko, Eli Lilly to Collaborate on Connected Insulin Pens
Glooko will partner with Eli Lilly for a strategic digital health collaboration using Eli Lilly’s connected insulin pens, the Tempo Pen and Tempo Smart...
Russ Johannesson on Setting the Pace in Digital Health
To make sure its upcoming connected insulin pen system will work with the user’s choice of daily diabetes management platforms, Eli Lilly & Co. has...
The Modernization of Clinical Trials: COVID-19’s Lasting Impact
In 2015, the Clinical Trial Transformation Initiative (CTTI) recommended that trial sponsors consider fully or partially decentralized DCTs, defined as...
Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19
As with so many aspects of our daily lives, the impact of the COVID-19 pandemic on clinical trials was both widespread and monumental. Thousands of trials—an...
How Glooko improves health outcomes by connecting people with diabetes and obesity and their healthcare professionals, enabling telehealth, clinical research, and better collaboration! Interview with Zach Henderson, Chief Commercial Officer at Glooko
COVID-19 has changed the way healthcare is delivered and has rapidly affected the virtual care adoption and usage. To manage better their day-to-day routine...
The startup behind a COVID-19 vaccine gears up for an IPO
The pandemic has turned lesser-known biopharmaceutical startups into household names, including vaccine developers Moderna and BioNTech. Now the company...
Diabetes management startup Glooko collects $30M to push remote monitoring, new therapy areas
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health...
Investors Ride High on the Telehealth Wave
One of the growing trends in the medtech industry is the rapid adoption of remote patient monitoring/telehealth. Glooko’s latest financing round is an...
The COVID-19 effect: Research platforms require new capabilities
With a shift to virtual/decentralized clinical trials, the popularity of decentralized clinical trials (DCTs) skyrocketed following the nationwide lockdown...
2021: Technology Trends and the Future of Medical Devices
While the far-reaching effects of COVID-19 have introduced the world to a “new normal,” the greatest impact has been in healthcare. In the long term,...
